Analgesic, anti-inflammatory and antiarthritic activity of newly synthesized bicyclothieno 1, 2, 3 - triazines

Macedonian Journal of Medical Sciences

Volumn 4, Issue 2, 2011, Pages 131-138

  Viswanatha, G L ^a   Akinapally, Nagaraju ^a   Shylaja, H ^a   Nandakumar, K ^b   Srinath, R ^a   Janardhanan, Saravanan ^a  

^a PES COLLEGE OF PHARMACY   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

1,2,3, Triazines; Analgesic Antiinflammatory activity and antiarthitic activity; CFA induced arthritis; Formalin induced edema; Formalin induced paw licking test; Hotplate test

Indexed keywords

BICYCLO THIENO 1,2,3 TRIAZINE DERIVATIVE; C REACTIVE PROTEIN; FORMALDEHYDE; FREUND ADJUVANT; RHEUMATOID FACTOR; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; LEUKOCYTE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAW EDEMA;

EID: 79959466324     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2011.0167     Document Type: Article

References (40)

1. Biesele JJ. Purine antagonism and differential toxicity of some imidazo-1, 2, 3-triazines in mouse- tumor tissue cultures. Cancer. 1952; 5(4):787-791.
2. Shaw E, Woolley DW. Imidazo-1, 2, 3-triazines as substrates and inhibitors for xanthine oxidase. J Biol Chem. 1952; 194(2):641-654.
3. Youssefyeh RD, Brown RE, Wilson J, Shah U, Jones H, Love B, et al. Pyrido[3/,2/:4,5] thieno [3,2-d]-N-triazines: a new series of orally active antiallergic agents. J Med Chem. 1984; 27:1639-1643.
4. Gatta F, Luciani M, Palazzo G. Pyrazolo [3, 4-d] pyrimidines related to lonidamine. J Heterocycl Chem. 1989; 26:613-618.
5. Dattolo G, Cirrincione G, Almerico AM, Aiello E. Polycondensed nitrogen heterocycles. part22. pyrrolo[3,4-d]-1,2,3-triazines: a new ring system as potential antineoplastic agent. J Heterocycl Chem. 1989; 26(6):1747-1749.
6. David KF. Preparation of 3-(azabicycloalkyl)-3, 4-dihydro- 4-oxobenzotriazines and quinazolines as 5-HT3 receptor antagonists. Chem Abst. 1990;112:7515m.
7. Siegfried L, Guenther W, Thomas S, Helmut V, Renate G. Preparation of 8,9,10,11-tetrahydro- 1,2,3-triazino[4/5/:4,5]-thieno[2,3-c] isoquinolines as antianaphylactics. Chem. Abst. 1990;113:40736c.
8. Monge A, Palop JA, Recalde JI, Fernandez Alvarez E. Synthesis of 1,2,3-triazino[5,4-b]indole-3-oxides. Platelet aggregation inhibitors. Chem Abst. 1990; 112:216880r.
9. Monge A, Aldana I, Arraras JA, Alvarez EF. Synthesis of 3- amino-5H-1,2,3-triazino[5,4-b]-indol-4-one. New compounds with blood platelet antiaggregation activity. J Heterocycl Chem. 1991; 28(3):557-560.
10. Manfredini S, Bazzanini R, Baraldi PG, Mario Guarneri M, Simoni D, Marongiu ME, et al. Pyrazole-related nucleosides. Synthesis and antiviral/antitumour activity of some substituted pyrazole and pyrazolo[4,3-d]-1,2,3- triazine-4-one nucleosides. J Med Chem. 1992;35:917-924.
11. Antonio M, Ignacio A, Maria F, Angel AJ, Esteban S, Jose IJ, et al. New indole and triazino [5, 4-b] indol-4-one derivatives: synthesis and studies as inotropics and inhibitors of blood platelet aggregation. Chem Abst. 1992;117:171387v.
12. Anthony WP, Martin CJ, Richard GC, Thomas SI. Preparation of me 3-methoxy-2-[2-(4-phenoxy-1, 2, 3-triazin-6-yloxy) phenyl] acrylates as agrochemical fungicides. Chem Abst. 1993; 118:147584g.
13. Thomas P, Peter Z, Wofram R, Rainer K. Preparation of heterocyclic carbamates as antithrombotics and elastase inhibitors. Chem Abst. 1995; 122:290895x.
14. Daidone G, Maggio B, Plescia S, Raffa D, Schillaci D, Migliara O, et al. Synthesis and pharmacological evaluation of 1-methyl-5- [substituted- 4(3H)-oxo-1,2,3- benzotriazin-3-yl]-1H-pyrazole-4-acetic acid derivatives. IL Farmaco. 1998; 53(5):350-356.
15. Quintela JM, Peinador C, Gonzalez LM, Riguera R, Rioja I, Terencio MC, et al. Synthesis and pharmacological evaluation of some 8- Cyanopyrido [3/,2/:4,5] thieno [3,2-d] triazine derivatives as inhibitors of nitric oxide and eicosanoid biosynthesis. J Med Chem. 1999; 42:4720-4724.
16. OECD 2001-gudeline on acute oral toxicity (AOT) Environmental health and safety monograph series on testing and adjustment No.425.
17. Vogel GH, Vogel WH, Scholkens BA, Sandow J, Muller G, Vogel WF. Drug discovery and evaluation Pharmacological assays. 2nd ed.Springer-Verlag, Berlin, 2002.
18. Hunskar S, Hole K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain. 1987; 30:103-114.
19. Helen WA, Alan C. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacol. 1991; 104(1): 35-44.
20. Winter EA, Nuss GV. Anti- Inflammatory and antipyretic activities of indomethacin. J. Pharmacol. Exptll Ther. 1963; 141: 369-376.
21. Tijani AY, Guru MOU, Salawu OA. Anti-pyretic, anti-inflammatory and anti-diarrhoeal properties of Faidherbia albida in rats. Afr J Biotechnol. 2008; 7(6): 696-700.
22. Newbould BB. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol Chemother. 1963; 21(1):127-136.
23. Singh S, Majumdar DK. Effect of fixed oil of Ocimum sanctum against experimentally induced arthritis and joint edema in laboratory animals. Int J Pharmacol. 1996; 34(3): 218-222.
24. Woolfe G, MacDonald AD. The evaluation of the analgesic action of Pethidine Hydrochloride. J Pharmacol Exp Ther. 1994; 80:300-07.
25. Hunskaar S, Fasmer OB, Hole K. Formalin test in mice, an useful technique for evaluating mild analgesics. J Neurosci Meth. 1985; 14:69-76.
26. Rosland JH, Tjølsen A, Mæhle B, Hole K. The formalin test in mice: Effect of formalin concentration. Pain. 1990; 42:235-242.
27. Christensen D, Idanpaan-Heikkila JJ, Guilbaud G, Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. Br J Pharmacol. 1998; 125:1641-1650.
28. Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Pain. 1994; 59:353-359.
29. Sakurada T, Wako K, Sugiyama A, Sakurada C, Tan-No K, Kisara K, et al. Involvement of spinal NMDA receptors in capsaicin-induced nociception. Pharmacol Biochem Behav. 1998; 59:339-345.
30. Nasstrom J, Karlsson U, Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol. 1992; 212:21-29.
31. Chizh BA. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: Review article. Amino Acids. 2002; 23(1-3):169-176.
32. Sarsat VW, Latscha BD. Neutrophil-derived oxidants and proteinases as Immunomodulatory mediators in inflammation. Mediators Inflamm. 1994; 3:257-273.
33. Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenan oedema in rats. J Pharmacol Exp Ther. 1969; 166: 96-103.
34. Eric GB, Lawrence JL. The text book of therapeutics drug and disease management. 16th ed. Williams and Wilkins Company: Baltimore; 1996.
35. Winder CV, Lembke LA, Stephens MD. Comparative bioassay of drugs in adjuvant-induced arthritis in rats: flufenamic acid, mefanamic acid and phenylbutazone. Arthritis Rheum.1969; 12(5):472-482.
36. Somasundaran S, Sadique J, Subramoniam A. Influence of extra-intestinal inflammation on the in vitro absorption of 14C-glucose and the effects of anti-inflammatroy drugs in the jejunum of rats. Clin Exp Pharmacol Physiol. 1983; 10(2): 147-152.
37. William JK. A Textbook Textbook of rheumatology. 3rd ed. Waverly Company: Tokyo; 1996.
38. Nielen MMJ, Schaardenburg DV, Reesink HW, Twisk JWR, Van der Stadt RJ, Horst Bruinsma IE, et al. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis. 2006; 65:535-537.
39. Yeh ET. CRP as a mediator of disease. Circulation. 2004; 109:11-14.
40. Oopman W. Rheumatoid factor and human disease. Clin. Immunol. News. 1990; 10:137-141.